176 related articles for article (PubMed ID: 27609087)
1. Casitas B-lineage lymphoma linker helix mutations found in myeloproliferative neoplasms affect conformation.
Buetow L; Tria G; Ahmed SF; Hock A; Dou H; Sibbet GJ; Svergun DI; Huang DT
BMC Biol; 2016 Sep; 14(1):76. PubMed ID: 27609087
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl.
Dou H; Buetow L; Hock A; Sibbet GJ; Vousden KH; Huang DT
Nat Struct Mol Biol; 2012 Jan; 19(2):184-92. PubMed ID: 22266821
[TBL] [Abstract][Full Text] [Related]
3. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
[TBL] [Abstract][Full Text] [Related]
4. E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis.
Ahmed SF; Buetow L; Gabrielsen M; Lilla S; Sibbet GJ; Sumpton D; Zanivan S; Hedley A; Clark W; Huang DT
Oncogene; 2021 Mar; 40(12):2149-2164. PubMed ID: 33627783
[TBL] [Abstract][Full Text] [Related]
5. Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders.
Naramura M; Nadeau S; Mohapatra B; Ahmad G; Mukhopadhyay C; Sattler M; Raja SM; Natarajan A; Band V; Band H
Oncotarget; 2011 Mar; 2(3):245-50. PubMed ID: 21422499
[TBL] [Abstract][Full Text] [Related]
6. Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor.
Bartkiewicz M; Houghton A; Baron R
J Biol Chem; 1999 Oct; 274(43):30887-95. PubMed ID: 10521482
[TBL] [Abstract][Full Text] [Related]
7. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.
Thien CB; Langdon WY
Oncogene; 1997 May; 14(18):2239-49. PubMed ID: 9174060
[TBL] [Abstract][Full Text] [Related]
8. The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
Visser GD; Lill NL
Exp Cell Res; 2005 Dec; 311(2):281-93. PubMed ID: 16246327
[TBL] [Abstract][Full Text] [Related]
9. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
Kassenbrock CK; Anderson SM
J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950
[TBL] [Abstract][Full Text] [Related]
10. Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases.
Polzer H; Janke H; Schmid D; Hiddemann W; Spiekermann K
Exp Hematol; 2013 Mar; 41(3):271-80.e4. PubMed ID: 23127761
[TBL] [Abstract][Full Text] [Related]
11. c-Cbl Expression Correlates with Human Colorectal Cancer Survival and Its Wnt/β-Catenin Suppressor Function Is Regulated by Tyr371 Phosphorylation.
Kumaradevan S; Lee SY; Richards S; Lyle C; Zhao Q; Tapan U; Jiangliu Y; Ghumman S; Walker J; Belghasem M; Arinze N; Kuhnen A; Weinberg J; Francis J; Hartshorn K; Kolachalama VB; Cifuentes D; Rahimi N; Chitalia VC
Am J Pathol; 2018 Aug; 188(8):1921-1933. PubMed ID: 30029779
[TBL] [Abstract][Full Text] [Related]
12. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene.
Andoniou CE; Thien CB; Langdon WY
EMBO J; 1994 Oct; 13(19):4515-23. PubMed ID: 7925293
[TBL] [Abstract][Full Text] [Related]
13. Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins.
Yokouchi M; Kondo T; Sanjay A; Houghton A; Yoshimura A; Komiya S; Zhang H; Baron R
J Biol Chem; 2001 Sep; 276(37):35185-93. PubMed ID: 11448952
[TBL] [Abstract][Full Text] [Related]
14. The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction.
Miyake S; Lupher ML; Andoniou CE; Lill NL; Ota S; Douillard P; Rao N; Band H
Crit Rev Oncog; 1997; 8(2-3):189-218. PubMed ID: 9570294
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib targets B-lineage cells but does not provide an effective therapy for myeloproliferative disease in c-Cbl RING finger mutant mice.
Duyvestyn JM; Taylor SJ; Dagger SA; Orandle M; Morse HC; Thien CB; Langdon WY
PLoS One; 2014; 9(4):e94717. PubMed ID: 24718698
[TBL] [Abstract][Full Text] [Related]
16. Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b.
Kobashigawa Y; Tomitaka A; Kumeta H; Noda NN; Yamaguchi M; Inagaki F
Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20579-84. PubMed ID: 22158902
[TBL] [Abstract][Full Text] [Related]
17. Differential ubiquitin binding of the UBA domains from human c-Cbl and Cbl-b: NMR structural and biochemical insights.
Zhou ZR; Gao HC; Zhou CJ; Chang YG; Hong J; Song AX; Lin DH; Hu HY
Protein Sci; 2008 Oct; 17(10):1805-14. PubMed ID: 18596201
[TBL] [Abstract][Full Text] [Related]
18. CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2.
Aranaz P; Hurtado C; Erquiaga I; Miguéliz I; Ormazábal C; Cristobal I; García-Delgado M; Novo FJ; Vizmanos JL
Haematologica; 2012 Aug; 97(8):1234-41. PubMed ID: 22315494
[TBL] [Abstract][Full Text] [Related]
19. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain.
Andoniou CE; Thien CB; Langdon WY
Oncogene; 1996 May; 12(9):1981-9. PubMed ID: 8649859
[TBL] [Abstract][Full Text] [Related]
20. Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant mice.
Taylor SJ; Thien CB; Dagger SA; Duyvestyn JM; Grove CS; Lee BH; Gilliland DG; Langdon WY
Exp Hematol; 2015 Mar; 43(3):191-206.e1. PubMed ID: 25534201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
